DCF Advisers’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,000
Closed -$2.33M 107
2023
Q3
$2.33M Sell
11,000
-650
-6% -$130K 1.27% 20
2023
Q2
$2.24M Sell
11,650
-500
-4% -$99.3K 1.18% 22
2023
Q1
$2.46M Sell
12,150
-300
-2% -$48.1K 1.51% 18
2022
Q4
$1.6M Buy
12,450
+700
+6% +$90.3K 1.08% 26
2022
Q3
$1.61M Sell
11,750
-3,250
-22% -$529K 1.04% 32
2022
Q2
$2.65M Hold
15,000
1.58% 21
2022
Q1
$2.16M Buy
15,000
+1,500
+11% +$203K 0.95% 31
2021
Q4
$2.09M Hold
13,500
0.85% 33
2021
Q3
$2.29M Hold
13,500
1.01% 29
2021
Q2
$2.13M Hold
13,500
0.76% 34
2021
Q1
$1.88M Buy
13,500
+200
+2% +$32.2K 0.82% 32
2020
Q4
$2.33M Buy
13,300
+300
+2% +$55.9K 0.96% 34
2020
Q3
$2.54M Sell
13,000
-1,000
-7% -$167K 1.3% 26
2020
Q2
$2.38M Sell
14,000
-3,000
-18% -$448K 1.33% 24
2020
Q1
$1.96M Hold
17,000
1.28% 26
2019
Q4
$1.94M Buy
+17,000
New +$1.8M 1.23% 27

Other funds holding SGEN

DCF Advisers's SGEN Position: Q4 2023 in Review

DCF Advisers sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 11,000 shares — an estimated $2.33M sold.

DCF Advisers first reported a position in SGEN in Q4 2019 and held it in 16 quarters. The position peaked at $2.65M in Q2 2022. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • DCF Advisers reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • DCF Advisers sold 11,000 Seagen Inc. Common Stock shares in Q4 2023, an estimated $2.33M.
  • DCF Advisers first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 16 quarters.
  • DCF Advisers's Seagen Inc. Common Stock position peaked at $2.65M in Q2 2022.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on DCF Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.